EUVIMEDEUVIMED entdecken
Crossref

Morbidity and mortality of newborn from preeclampsia mother with SARS-CoV-2 infection

S N Lumbanraja, I H Effendi, A Siahaan, B E P Bancin, T Sinurat

Journal of Neonatal-Perinatal Medicine · 2023

DOI: 10.3233/npm-220002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neonatal-Perinatal Medicine, 2023. Verfasst von S N Lumbanraja und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstertrics and Gyenecology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia. Hauptthemen laut MEDLINE: Pre-Eclampsia, COVID-19, Pregnancy Complications, Infectious. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Preeclampsia is a major cause of maternal and infant mortality in Indonesia. Several studies have investigated the association between SARS-CoV-2 infection and adverse maternal, fetal, and neonatal outcomes. The studies found that SARS-CoV-2 infection during pregnancy is associated with an increased risk of maternal morbidity and mortality related to hypertensive disorders, including preeclampsia. However, the studies did not provide specific information on the morbidity and mortality of newborns from mothers diagnosed with preeclampsia with conjunction SARS-CoV-2 infection. METHODS: This hospital-based case-control study was conducted on 28 mother-infant pairs using a systematic sampling method from February 2021 to December 2021. Data were analyzed using SPSS software (version 26), and statistical tests including chi-square analysis, Fisher’s exact test, Mann-Whitney U-test and independent t-test were performed to identify factors associated with study variables in a 95% confidence interval (CI). RESULTS: We conducted a prospective study involving the enrollment of 28 pregnant women with confirmed SARS-CoV-2 infection through RT-PCR tests. Within this cohort, a subset of 4 mothers (14.8%) were diagnosed with preeclampsia. Four preeclamptic patients (100%) experienced fatal outcomes. Furthermore, among the infants born to preeclamptic mothers with SARS-CoV-2 infections, two (50%) newborns not survive. One infant passed away shortly after birth at 30 weeks of gestation, while the other had intrauterine demise at 28 weeks of gestation. CONCLUSIONS: SARS-CoV-2 infection during pregnancy is associated with an increased risk of maternal morbidity and mortality related preeclampsia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaCOVID-19Pregnancy Complications, InfectiousHumansFemalePregnancyInfant, NewbornAdultIndonesiaCase-Control StudiesSARS-CoV-2Prospective StudiesInfant MortalityInfectious Disease Transmission, VerticalPregnancy Outcome

Stichwörter der Autor:innen

MorbiditySARS-CoV-2mortalitynewbornpreeclampsia

Autor:innen und Institutionen

  • Department of Obstertrics and Gyenecology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
  • Department of Neurosurgery, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
  • Department of Pediatrics, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.

Zitieren

APA

Lumbanraja, S. N., Effendi, I. H., Siahaan, A., Bancin, B. E. P., & Sinurat, T. (2023). Morbidity and mortality of newborn from preeclampsia mother with SARS-CoV-2 infection. Journal of Neonatal-Perinatal Medicine. https://doi.org/10.3233/npm-220002

Vancouver

Lumbanraja SN, Effendi IH, Siahaan A, Bancin BEP, Sinurat T. Morbidity and mortality of newborn from preeclampsia mother with SARS-CoV-2 infection. Journal of Neonatal-Perinatal Medicine. 2023. doi:10.3233/npm-220002

BibTeX
@article{Lumbanraja2023,
  author = {Lumbanraja, S N and Effendi, I H and Siahaan, A and Bancin, B E P and Sinurat, T},
  title = {Morbidity and mortality of newborn from preeclampsia mother with SARS-CoV-2 infection},
  journal = {Journal of Neonatal-Perinatal Medicine},
  year = {2023},
  doi = {10.3233/npm-220002}
}
Kostenlos starten →